The Saudi Association for the Study of Liver Diseases and Transplantation Clinical Practice Guidelines for Management of Autoimmune Hepatitis

Overview

Journal Saudi J Gastroenterol

Specialty Gastroenterology

Date 2018 Sep 29

PMID 30264737

Citations 6

Authors

Abdulrahman A Aljumah

Badr Al Jarallah

Ali Albenmousa

Abdullah Al Khathlan

Adnan Al Zanbagi

Mohammed Al Quaiz

Bandar Al-Judaibi

Khalid Nabrawi

Waleed Al Hamoudi

Mohammed Alghamdi

Hind Fallatah

Affiliations

Soon will be listed here.

Citing Articles

Biochemical markers to detect protein malnutrition in type 2 diabetes and liver cirrhosis patients.

Mohammedsaeed W, Binjawhar D, Surrati A Medicine (Baltimore). 2025; 104(5):e41376.

PMID: 39889178 PMC: 11789901. DOI: 10.1097/MD.0000000000041376.

Have serum vitamin D and ferritin a role in predicting the prognosis of autoimmune hepatitis treatment in children?.

Nagi S, Yehia S, Elhagali Y, Elkholy S, Abd-Elaati B Clin Exp Hepatol. 2024; 10(1):53-61.

PMID: 38765911 PMC: 11100337. DOI: 10.5114/ceh.2024.136927.

Retrospective, single-center analysis of autoimmune hepatitis in Jordanian children: clinical features, treatments, and outcomes.

Altamimi E, Al Omari D, Obeidat H, Barham K BMC Pediatr. 2024; 24(1):102.

PMID: 38331749 PMC: 10851525. DOI: 10.1186/s12887-024-04590-9.

Clinical characteristics, diagnosis and management of Sweet syndrome induced by azathioprine.

Fan Z, He Y, Sun W, Li Z, Ye C, Wang C Clin Exp Med. 2023; 23(7):3581-3587.

PMID: 37432535 DOI: 10.1007/s10238-023-01135-9.

Efficacy of ursodeoxycholic acid for primary biliary cholangitis: Experience from a tertiary care centre in Saudi Arabia.

AlWabel A, Peedikayil M, Alnasser S, AlHusaini K, AlHekail O, Alqahtani S Saudi J Gastroenterol. 2022; 29(2):135-140.

PMID: 35229756 PMC: 10270471. DOI: 10.4103/sjg.sjg_445_21.

References

Manns M, Czaja A, Gorham J, Krawitt E, Mieli-Vergani G, Vergani D . Diagnosis and management of autoimmune hepatitis. Hepatology. 2010; 51(6):2193-213. DOI: 10.1002/hep.23584. View

Bjornsson E, Talwalkar J, Treeprasertsuk S, Kamath P, Takahashi N, Sanderson S . Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology. 2010; 51(6):2040-8. DOI: 10.1002/hep.23588. View

Abdo A, Bain V, Kichian K, Lee S . Evolution of autoimmune hepatitis to primary sclerosing cholangitis: A sequential syndrome. Hepatology. 2002; 36(6):1393-9. DOI: 10.1053/jhep.2002.37200. View

Czaja A . Comparability of probable and definite autoimmune hepatitis by international diagnostic scoring criteria. Gastroenterology. 2011; 140(5):1472-80. DOI: 10.1053/j.gastro.2011.02.010. View

Czaja A . Treatment strategies in autoimmune hepatitis. Clin Liver Dis. 2002; 6(3):799-824. DOI: 10.1016/s1089-3261(02)00028-4. View

Czaja A, Menon K, Carpenter H . Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: a retrospective analysis. Hepatology. 2002; 35(4):890-7. DOI: 10.1053/jhep.2002.32485. View

Stellon A, Keating J, Johnson P, McFarlane I, Williams R . Maintenance of remission in autoimmune chronic active hepatitis with azathioprine after corticosteroid withdrawal. Hepatology. 1988; 8(4):781-4. DOI: 10.1002/hep.1840080414. View

Gleeson D, Heneghan M . British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis. Gut. 2011; 60(12):1611-29. DOI: 10.1136/gut.2010.235259. View

Chapman M, Kajihara M, Borges G, OBeirne J, Patch D, Dhillon A . Severe, acute liver injury and khat leaves. N Engl J Med. 2010; 362(17):1642-4. DOI: 10.1056/NEJMc0908038. View

10.

Hartl J, Denzer U, Ehlken H, Zenouzi R, Peiseler M, Sebode M . Transient elastography in autoimmune hepatitis: Timing determines the impact of inflammation and fibrosis. J Hepatol. 2016; 65(4):769-775. DOI: 10.1016/j.jhep.2016.05.023. View

11.

Braga A, Vasconcelos C, Braga J . Pregnancy with autoimmune hepatitis. Gastroenterol Hepatol Bed Bench. 2016; 9(3):220-4. PMC: 4947137. View

12.

Montano-Loza A, Mason A, Ma M, Bastiampillai R, Bain V, Tandon P . Risk factors for recurrence of autoimmune hepatitis after liver transplantation. Liver Transpl. 2009; 15(10):1254-61. DOI: 10.1002/lt.21796. View

13.

Tang C, Shiau Y, Huang Y, Tsay S, Huo T, Wu J . Cholestatic jaundice as the predominant presentation in a patient with autoimmune hepatitis. J Chin Med Assoc. 2008; 71(1):45-8. DOI: 10.1016/S1726-4901(08)70072-8. View

14.

Hegarty J, Nouri Aria K, Portmann B, Eddleston A, Williams R . Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis. Hepatology. 1983; 3(5):685-9. DOI: 10.1002/hep.1840030510. View

15.

Czaja A, Carpenter H . Histological features associated with relapse after corticosteroid withdrawal in type 1 autoimmune hepatitis. Liver Int. 2003; 23(2):116-23. DOI: 10.1034/j.1600-0676.2003.00810.x. View

16.

Gregorio G, Portmann B, Karani J, Harrison P, Donaldson P, Vergani D . Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology. 2001; 33(3):544-53. DOI: 10.1053/jhep.2001.22131. View

17.

Miyake Y, Iwasaki Y, Terada R, Onishi T, Okamoto R, Sakai N . Clinical characteristics of fulminant-type autoimmune hepatitis: an analysis of eleven cases. Aliment Pharmacol Ther. 2006; 23(9):1347-53. DOI: 10.1111/j.1365-2036.2006.02894.x. View

18.

Trivedi P, Hirschfield G . Treatment of autoimmune liver disease: current and future therapeutic options. Ther Adv Chronic Dis. 2013; 4(3):119-41. PMC: 3629750. DOI: 10.1177/2040622313478646. View

19.

Feld J, Dinh H, Arenovich T, Marcus V, Wanless I, Heathcote E . Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome. Hepatology. 2005; 42(1):53-62. DOI: 10.1002/hep.20732. View

20.

Schramm C, Herkel J, Beuers U, Kanzler S, Galle P, Lohse A . Pregnancy in autoimmune hepatitis: outcome and risk factors. Am J Gastroenterol. 2006; 101(3):556-60. DOI: 10.1111/j.1572-0241.2006.00479.x. View